Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8231417 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
The progression of CP class after SBRT limits other additional local treatments and also reflects the deterioration of hepatic function. Therefore, it would be important to note that the presence or absence of the progression of CP class is a dose-limiting factor. The total liver volume receiving <18 Gy should be greater than 800 cm3 to reduce the risk of the deterioration of hepatic function.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Seok Hyun M.D., Byung Ock M.D., Mi Ryeong M.D., Young Nam Ph.D., Ji Sun M.S., Si Hyun M.D., Seung Kew M.D., Ihl Bohng M.D., Ki Mun M.D., Hong Seok M.D.,